Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • epistatic
    Senior Member
    • Mar 2009
    • 129

    #1

    AmpliSeq vs TruSeq custom amplicon

    I have three genes that I want to capture and sequence in an initial 250 patient samples. I wanted to do a comparison between Illumina's new custom amplicon/golden gate and Ion Torrent's AmpliSeq.

    It looks best to wait until they launch in March. Fair enough rules for early access?

    Use Ion AmpliSeq Designer, our free and easy yet powerful custom NGS panel design tool, to take your NGS testing in the direction you need.


    5. LTC retains all right, title and interest in and to any Custom Product provided hereunder and grants you a non-exclusive, non-transferable, non-sublicensable license to use such Custom Product solely for your internal research purposes. Commercial use of such Custom Product is expressly prohibited.

    6. Within thirty (30) days of a request by LTC and to the extent so requested, you will provide data resulting from your analysis or testing of the Products (collectively, the “Test Results”), or a summary thereof, in writing to LTC. You shall permit LTC to use the Test Results for Product improvement purposes.

    7. You shall not publish, disseminate, or otherwise share the Test Results relating to the Products without LTC’s prior express written consent.

    8. Any information provided by LTC related to the Products, including, without limitation, any protocols or data, is provided “as is” and shall not be supported by LTC.

    9. You shall promptly disclose any improvement that relates to (a) configuration, composition, use, manufacturing, layout, or packaging of any Product; and/or (b) software and techniques relating to the extraction, manipulation, processing, analysis or storage of data ("Product Improvements"). "Product Improvements" shall not include data generated using the Product or discoveries derived therefrom (except as expressly set forth in (a) – (b) above). Except to the extent prohibited by applicable laws, you hereby grant to LTC a non-exclusive, worldwide, fully sublicensable, fully paid-up, royalty-free, irrevocable, perpetual license to all Product Improvements.

    10. You will be signed up to wash and wax the Ion Bus. http://www.iontorrent.com/ionbus?CID=0003GZ_20120207
    Last edited by epistatic; 02-08-2012, 10:51 AM.
  • Elcannibal
    Member
    • Jan 2012
    • 48

    #2
    Interesting... reminds me of old Taqman days... When it was time to actual licence things, AB would never get back to us or even transfer our demans properly. That being said, there are other sample prep solutions out there. Have you checked into the Access Array from fluidigm, there is a capital cost but if the sample size is high enough, the routine work becomes inexpensive.

    Comment

    • Andrew_Slatter
      Member
      • Dec 2010
      • 12

      #3
      We are launching our GenomePooling technology, that allows users to pool multiplexed tagged genomes of up to 384 samples, followed by region of interest extraction and NGS on any platform. Pooled genome libraries can be reused for subsequent extractions, thus removing the need for repeat sample preps.

      If you are interested go to our website and contact us:

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:05 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-13-2026, 12:22 PM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Working...